Saturday - September 13, 2025
European Society of Cardiology: Olezarsen Reduces Levels of the Blood Fat, Triglycerides, in Patients at High Cardiovascular Risk
August 30, 2025
SOPHIA ANTIPOLIS, France, Aug. 30 -- The European Society of Cardiology issued the following news release:

* * *

Olezarsen reduces levels of the blood fat, triglycerides, in patients at high cardiovascular risk

* An unmet need exists for effective therapies to lower triglyceride levels in patients with residual cardiovascular risk despite optimal lipid-lowering therapies.

* The ESSENCE-TIMI 73b trial investigated the efficacy and safety of the . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products